Voloridge Investment Management LLC Makes New Investment in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Voloridge Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 1,294,589 shares of the medical instruments supplier's stock, valued at approximately $24,571,000. Voloridge Investment Management LLC owned approximately 0.65% of DENTSPLY SIRONA at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp grew its holdings in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after purchasing an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after purchasing an additional 35,360 shares during the period. Barclays PLC grew its stake in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after buying an additional 54,920 shares during the last quarter. Canvas Wealth Advisors LLC increased its position in DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier's stock worth $6,245,000 after buying an additional 182,234 shares during the period. Finally, Nisa Investment Advisors LLC increased its position in DENTSPLY SIRONA by 89.6% during the fourth quarter. Nisa Investment Advisors LLC now owns 54,397 shares of the medical instruments supplier's stock worth $1,041,000 after buying an additional 25,705 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on XRAY shares. Mizuho decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Barrington Research upped their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, May 12th. Finally, Morgan Stanley downgraded shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock traded up $0.66 on Tuesday, reaching $16.13. 562,576 shares of the stock were exchanged, compared to its average volume of 2,959,270. The firm has a market capitalization of $3.21 billion, a PE ratio of -7.79, a PEG ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $28.25. The business has a fifty day moving average price of $14.47 and a two-hundred day moving average price of $17.07. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's quarterly revenue was down 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.42 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.97%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.10%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.50% of the stock is owned by corporate insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.